Crinetics Pharmaceuticals: Funding, Investors & Team (Sep 2026)
This place is about more than a pharmaceutical career. It’s about making a real difference in the lives of patients. That’s why we’re here. That’s why you should maybe think about being here, too. Our mission is to build the leading endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. Working to accomplish this mission is how we bring our vision to life. For us, that vision is the best possible therapeutics available to all patients with diseases of the endocrine system. We love how that sounds. And we really can’t wait to know how it feels.
Crinetics Pharmaceuticals has raised $625M across 2 funding rounds on record, the most recent an undisclosed round of $500M announced in Oct 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Crinetics Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Crinetics Pharmaceuticals Funding Rounds
Crinetics Pharmaceuticals raised $125M in a Post-IPO Equity announced in Apr 2022.
2.5 years later, an undisclosed round of $500M was announced in Oct 2024.
Crinetics Pharmaceuticals Founders and Leadership Team
Contact details for the Crinetics Pharmaceuticals team: 1 of 2 have an email address on file.
Start 14-day free trial →Crinetics Pharmaceuticals Funding Compared to Other Biotechnology Startups
Crinetics Pharmaceuticals' latest round of $500M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Crinetics Pharmaceuticals in Biotechnology and San Diego
Companies Similar to Crinetics Pharmaceuticals
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Crinetics Pharmaceuticals Funding FAQs
What does Crinetics Pharmaceuticals do?
This place is about more than a pharmaceutical career. It’s about making a real difference in the lives of patients. That’s why we’re here. That’s why you should maybe think about being here, too. Our mission is to build the leading endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. Working to accomplish this mission is how we bring our vision to life. For us, that vision is the best possible therapeutics available to all patients with diseases of the endocrine system. We love how that sounds. And we really can’t wait to know how it feels.
How much funding has Crinetics Pharmaceuticals raised?
Crinetics Pharmaceuticals has raised $625M across 2 rounds on record. The most recent is an undisclosed round of $500M announced in Oct 2024.
When did Crinetics Pharmaceuticals last raise funding?
Crinetics Pharmaceuticals' most recent funding round on record is an undisclosed round of $500M, announced in Oct 2024.
Who founded Crinetics Pharmaceuticals?
FundedIQ lists Yun Fei Zhu (Founder) at Crinetics Pharmaceuticals.
Who is the CEO of Crinetics Pharmaceuticals?
Scott Struthers is listed as CEO at Crinetics Pharmaceuticals.
Where is Crinetics Pharmaceuticals headquartered?
Crinetics Pharmaceuticals is based in San Diego, California, United States.
How many employees does Crinetics Pharmaceuticals have?
Crinetics Pharmaceuticals is in the 101-250 employee band.
How does Crinetics Pharmaceuticals' funding compare to other Biotechnology startups?
Crinetics Pharmaceuticals' latest round of $500M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Crinetics Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Crinetics Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.